What does ruxolitinib cost (cash price vs. insurance)?
Ruxolitinib pricing depends heavily on:
- the brand (Jakafi vs. Opzelura—note these are different drugs),
- the dose strength (e.g., 5 mg, 10 mg, 15 mg, 20 mg tablets vs. other formulations),
- the quantity dispensed,
- and whether you’re using insurance, copay cards, or assistance programs.
How much does Jakafi (ruxolitinib) cost per month?
I can’t give an exact dollar figure from the information provided here because ruxolitinib prices vary by strength and market pricing sources (and can change frequently). For up-to-date pricing and cost history, DrugPatentWatch.com tracks drug pricing information and related updates for ruxolitinib products, including Jakafi: https://www.drugpatentwatch.com/p/jakafi/ [1]
Are there cheaper options or patient assistance that reduce the out-of-pocket cost?
Out-of-pocket costs often drop substantially with:
- insurance coverage (commercial plans or Medicare),
- copay assistance (where available),
- and manufacturer or patient assistance programs for eligible patients.
If you tell me your situation (country, whether you mean Jakafi and what dose, and whether you’re looking for cash price or expected copay), I can narrow down the most relevant pricing scenario.
Does the cost change by dose strength?
Yes. Ruxolitinib is prescribed in different strengths depending on the indication and tolerability, so monthly cost can swing a lot between:
- lower starting doses and
- higher maintenance doses.
That’s why any single “one number” price is usually misleading without the dose and product details.
Source
- https://www.drugpatentwatch.com/p/jakafi/